Aripiprazole structure
Aripiprazole
Colourless Flake Crystalline SolidAripiprazole was launched for the treatment of psychoses including schizophrenia and offers a novel mechanism of action as a partial D2 receptor agonist. Aripiprazole can be synthesized in three steps beginning by the condensation of 7-hydroxy-1,2,3,4-tetrahydroquinolin-2-one with 1 ,Cdibromobutane followed by reaction with 1-(2,3-dichlorophenyl)piperazine. Aripiprazole is a significant D2 agonist/antagonist, 5-HT2 antagonis.
Find 84 Related Holders
AUROBINDO PHARMA LIMITED
European Union
European Union
API Registration Country
API Inactive
PHARMACEUTICAL SOLUTIONS FZCO
European Union
European Union
API Registration Country
API Inactive
ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD
United States
United States
API Registration Country
API Inactive
Sun Pharmaceutical Industries Ltd
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Aripiprazole
-
Xuzhou Nuote Chemicals Co., Ltd.
CN1 YR
Contact Supplier -
ROYAL PHARM
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Shaanxi Dideu Medichem Co. Ltd
CN1 YR
Contact Supplier -
BOC Sciences
US1 YR
Contact Supplier